NeuroNews’ Post

Medtronic receives CE-Mark approval for #Inceptiv closed-loop SCS to treat chronic pain. The rechargeable spinal cord stimulator is "the only SCS system in Europe" offering both full-body 1.5T and 3T MRI access, Medtronic claims the Inceptiv #neurostimulator is "the thinnest SCS device in the world" at just 6mm. It offers the proven benefits of Medtronic’s proprietary DTM SCS therapy and the system’s battery can be recharged from empty to full in approximately one hour. The Inceptiv SCS system will be commercially available "in the coming months" in Europe, but is currently not approved for sale or distribution in the USA. What do you think of this approval for the #chronicpain industry and its patients? Full article in the comments

First of many Atypical Flutters addressed by @MDT_EPAblation Pulseselect PFA..smaller catheter design allows for targeted ablation. Most important marker for termination is contact as determined by 2mm proximity map with HD grid!also addresses epicardial jump! Abbott Medtronic Cardiac and Vascular #Epeeps

Exploring Endovascular Management Options: Ruby Peripheral Embolization System➡️ https://ow.ly/vPlu50PWb7x This breakout is supported by Penumbra, Inc. #Vascular #MedEd #VIOCongress2023 #VIO2023

//PulseSelect, designed to treat atrial fibrillation (AFib), is a key piece of Medtronic’s cardiac ablation portfolio. It uses PFA to target a patient’s pulmonary veins with 30-second bursts of energy. In trials, pulsed field has the same level of efficacy as traditional thermal ablation using RF or cryo-ablation. However, the safety profile is much greater, because the technology uses energy bursts to create electroporation, where holes developed in cells that lead to cell death, which is easier to control and helps prevent damage to underlying tissues such as the esophagus.// #medicaldevices #cardiovascular #cardiacablation #atrialfibrillation #safety #medicaldevicenews

It's Q & A Thursday! Question: When selective renal angiography (36251-36254) is performed followed by stent placement in a renal artery, can catheterization for the stent placement be coded separately? Answer: No. The catheter work is already bundled into codes 36251 - 36254 even though catheterization may be reported with code 37236. As a general rule, when catheterization is bundled with one of two codes reported for the same vessel, it will be bundled for both procedures. #qandathursday #radrx #crackingtheIRcode #circc #interventionalradiologycoding #ivrcoding #ircoding

Have you ever faced issues performing BASE in severely calcified CTOs? #IVL Shockwave Medical can help. IVL-facilitated BASE for #CTO #PCI

Online now in GIE’s Articles in Press: “Top tips for endoscopic therapy for radiation-associated vascular ectasias in the rectum (with video)” by Arvind J. Trindade. Find it at https://lnkd.in/gipBePBw.

Medtronic receives #FDA approval for their Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) 🧠 💪 It is the first of its kind to offer a closed-loop feature, automatically adjusting stimulation in real time to keep therapy in sync with daily activities. Traditional SCS devices may cause discomfort during certain movements, leading to suboptimal therapy experiences. Inceptiv is able to sense biological signals and maintain tailored stimulation, ensuring a more consistent and effective treatment. David Carr, VP and General Manager for Pain Intervention at Medronic said: "A new era for spinal cord stimulation technology is beginning, and with Inceptiv SCS, Medtronic is at the forefront," "For patients dealing with chronic pain, every day is a struggle. They deserve personalized and effective relief, without compromising future access to MRI. They deserve the comfort that the smallest and thinnest device on the market can provide. We are proud to offer the most cutting-edge solution available today with Inceptiv SCS." Medtronic will initiate the U.S. market launch of Inceptiv in the coming weeks. #neurotech #spinalcordstimulation #medicaldevice

We are pleased to announce that the RECOIL BTK Study has been published in the Journal of Endovascular Therapy! This groundbreaking study was core lab adjudicated and demonstrated a statistically significant difference between BTK lesions treated with #Serranator and Plain Balloon. The Serranator group’s low 6% average recoil represents an 89% reduction from the 55% average recoil seen in the POBA group! Read the full paper here: https://lnkd.in/eJCqrFyG #SerrateAndInflate #RestoringBloodFlowRestoringLife #SavingLimbs